{"@id":"https://bioecon.ru/technology/biologics-cdmo-contract-bio-manufacturing/","@type":"Technology","cluster":"market-access-commercial","formats":{"html":"https://cn.bioecon.ru/technology/biologics-cdmo-contract-bio-manufacturing/","json":"https://cn.bioecon.ru/api/v1/technology/biologics-cdmo-contract-bio-manufacturing/index.json"},"id":"biologics-cdmo-contract-bio-manufacturing","industries":["services"],"lang":"cn","links":{"industries":["https://bioecon.ru/industries/services/"],"suppliers":["https://bioecon.ru/companies/wuxi-biologics/","https://bioecon.ru/companies/boehringer-ingelheim/","https://bioecon.ru/companies/samsung-biologics/","https://bioecon.ru/companies/lonza-group/","https://bioecon.ru/companies/biophenolics-inc/","https://bioecon.ru/companies/good-meat/","https://bioecon.ru/companies/ajinomoto/","https://bioecon.ru/companies/agc-biologics/","https://bioecon.ru/companies/amgen/","https://bioecon.ru/companies/pow-bio/","https://bioecon.ru/companies/wuxi-apptec/"]},"maturity":8,"name":"生物药CDMO（合同生物制造）","regions":["us","cn","eu"],"risk":"medium","section":"technology","sector":"services-governance-capital","sources":[{"date":"2026-11-08","entity":"wuxibiologics.com","kind":"web","urls":["https://www.wuxibiologics.com/wp-content/uploads/WuXi-Bio-Capabilities-Overview-082825-E.pdf","https://www.wuxibiologics.com/capabilities/late-stage-development/","https://www.wuxibiologics.com/capabilities/commercial-dp-manufacturing/"]},{"date":"2026-11-08","entity":"pharmoutsourcing.com","kind":"web","urls":["https://www.pharmoutsourcing.com/Featured-Articles/339549-Trends-in-Biopharma-Contract-Manufacturing-in-China-and-India/"]}],"stages":[{"n":1,"title":"开发与转移"},{"n":2,"title":"表征与验证"},{"n":3,"title":"GMP生产"},{"n":4,"title":"灌装与放行"}],"summary":"生物药从概念到商业化的外包开发与生产——成熟且受FDA、EMA和NMPA的GMP监管；2015年中国MAH试点向合同生产企业打开了市场。","url":"/technology/biologics-cdmo-contract-bio-manufacturing/","verified":"2026-11-08"}